Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v5-FR Version v2-FR
Language French French
Date Updated 2021-02-23 2021-01-11
Drug Identification Number 02490544 02490544
Brand name MINT-LACOSAMIDE MINT-LACOSAMIDE
Common or Proper name Lacosaminde Lacosaminde
Company Name MINT PHARMACEUTICALS INC MINT PHARMACEUTICALS INC
Ingredients LACOSAMIDE LACOSAMIDE
Strength(s) 50MG 50MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size 60 count bottles 60 count bottles
ATC code N03AX N03AX
ATC description ANTIEPILEPTICS ANTIEPILEPTICS
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date
Actual start date 2021-01-11 2021-01-11
Estimated end date 2021-01-30
Actual end date 2021-02-10
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments